Your browser doesn't support javascript.
loading
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial.
Bauer, Sebastian; Jones, Robin L; Blay, Jean-Yves; Gelderblom, Hans; George, Suzanne; Schöffski, Patrick; von Mehren, Margaret; Zalcberg, John R; Kang, Yoon-Koo; Razak, Albiruni Abdul; Trent, Jonathan; Attia, Steven; Le Cesne, Axel; Su, Ying; Meade, Julie; Wang, Tao; Sherman, Matthew L; Ruiz-Soto, Rodrigo; Heinrich, Michael C.
Affiliation
  • Bauer S; Department of Medical Oncology and Sarcoma Center, University Hospital Essen, Essen, Germany.
  • Jones RL; German Cancer Consortium (DKTK), Partner Site Essen, Germany.
  • Blay JY; Sarcoma Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.
  • Gelderblom H; Centre Léon Bérard, Lyon, France.
  • George S; Leiden University Medical Center, Leiden, the Netherlands.
  • Schöffski P; Dana-Farber Cancer Institute, Boston, MA.
  • von Mehren M; Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven, University Hospitals Leuven, Leuven, Belgium.
  • Zalcberg JR; Fox Chase Cancer Center, Philadelphia, PA.
  • Kang YK; Monash University School of Public Health and Preventive Medicine and Department of Medical Oncology, Alfred Health, Melbourne, Victoria, Australia.
  • Razak AA; Asan Medical Center, University of Ulsan, Seoul, South Korea.
  • Trent J; Toronto Sarcoma Program, Princess Margaret Cancer Center, Toronto, ON, Canada.
  • Attia S; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL.
  • Le Cesne A; Mayo Clinic, Jacksonville, FL.
  • Su Y; Gustave Roussy, Villejuif, France.
  • Meade J; Deciphera Pharmaceuticals, LLC, Waltham, MA.
  • Wang T; Deciphera Pharmaceuticals, LLC, Waltham, MA.
  • Sherman ML; Deciphera Pharmaceuticals, LLC, Waltham, MA.
  • Ruiz-Soto R; Deciphera Pharmaceuticals, LLC, Waltham, MA.
  • Heinrich MC; Deciphera Pharmaceuticals, LLC, Waltham, MA.
J Clin Oncol ; 40(34): 3918-3928, 2022 12 01.
Article in En | MEDLINE | ID: mdl-35947817
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Stromal Tumors / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Clin Oncol Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Stromal Tumors / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Clin Oncol Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United States